Keep up to date with all the latest ARMI news and events. We know your inbox is overflowing, so we promise to only share important news and events with you – we hate SPAM too.
Rishika Turaga: ARMI’s Newest Social Media Ambassador
ARMI’s Master’s student Rishika Turaga is the newest recruit of the Institute’s Social Media Ambassador Program. As an Ambassador, Rishika will be mentored in using social media professionally and in science communications. “I think connectivity and sharing knowledge in science and social media’s role are critical,” commented Rishika. “If you want to talk to researchers, […]
Monash biotech start-up receives funding for muscular dystrophies
A new Monash biotech company has received funding to develop novel therapies for treatment of muscular dystrophies. Myostellar, established by researchers from Monash’s Australian Regenerative Medicine Institute (ARMI), has been awarded a $500,000 grant from CUREator, a national biomedical incubator managed by life science collaboration Brandon BioCatalyst. Professor Peter Currie, who is leading the project alongside […]
New Grant to Galvanise ARMI and AstraZeneca Collaboration to boost macrophage-based technologies for tissue regeneration
A three-year grant from the Australian Research Council will help strengthen the partnership between Australian Regenerative Medicine Institute (ARMI) and AstraZeneca. The $AUD857,800 grant will enable critical research into developing macrophage-based technologies for tissue regeneration to be conducted by a multidisciplinary team led by Professor Peter Currie and Associate Professor Mikaël Martino at ARMI and […]
Regen Med Researcher Recognised by Victorian Premier’s Awards
Dr Xiaodong (Ethan) Liu, a regenerative medicine researcher, based at the Monash Biomedicine Discovery Institute (BDI) and Australian Regenerative Medicine Institute (ARMI), was announced a winner at the Victorian Premier’s Awards for Health and Medical Research in a ceremony on 4 April 2022 at Deakin Edge. Xiaodong was also named the winner of the Basic […]
Putting the Medicine in Regenerative Medicine
The translation and commercialisation of medicines and technologies is a long and complex process that can cost billions of dollars. While these advances have the potential to disrupt industries and improve the quality of life for patients, only a small fraction of these ever “escape” the laboratory and fulfil their potential. Identifying market applications in […]
Interview with Professor Alan Trounson, CEO of Cartherics
Cartherics’ partnership with ARMI and CCRM Australia is another step towards synergy between industry and academia in Australia’s biotechnology sector. CEO of Cartherics, Professor Alan Trounson AO, shares his views on the collaboration, translating medical research in Australia and the future of regenerative medicine. Q: What value does this partnership between ARMI, Cartherics and CCRM […]
The Diversification of ARMI’s Industry Advisory Committee
The ability to unlimitedly self-renew and develop into numerous cell types has made regenerative medicine a growing discipline of medical research. A strength of ARMI’s research program is the diversity of topic areas, ranging from organ engineering and synthetic biology to immunity and regeneration, all of which have commercial promise. In addition to cell-based therapies […]
Dr. Meroula Richardson: From childhood on a farm to a leading cardiologist to ARMILAB
As a cardiologist, regenerative medicine holds enormous appeal for Dr. Meroula Richardson. “Transplantation and heart failure therapies are great – but they are treatment, not a cure,” said Meroula. “The potential for molecular and cell-based therapy to provide a cure is both real and exciting.” That is part of why Meroula has joined ARMI’s Leadership […]
Fellowship Awarded to ARMI Scientist to Accelerate the Development of Novel Regenerative Medicine Technologies
ARMI group leader Associate Professor Mikaël Martino has been awarded a coveted Senior Medical Research Fellowship from the Sylvia and Charles Viertel Charitable Foundation to develop novel regenerative medicine technologies. This grant will provide $1.25 million over five years to assist the Martino group’s objective of developing novel regeneration methods combining bioengineering and modulation of […]
End of Year Address from the Director, Professor Peter Currie
Despite another year disrupted by the COVID-19 pandemic, 2021 was a year of tremendous achievement at ARMI. From excellent scientific output to the continued camaraderie amongst ARMI staff and students, ARMI Director of Research Professor Peter Currie reflects on the past year and looks to the future with great optimism. Q: What were your highlights […]